The DOI matches its Crossref record; 136 of the 155 references it cites were found in a registry or an index.
Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: a meta-analysis
Abstract
Functional gastrointestinal disorders impact 40% of the global population, with irritable bowel syndrome (IBS) standing out due to its complexity, quality-of-life effects, and economic impact. Our meta-analysis explored the global prevalence of IBS, considering diagnostic criteria, subtypes, sampling methods, geographical variations, and risk factors. The literature search used databases like PubMed and Cochrane Library, focusing on IBS studies from 2006 to June 2024. Eligibility criteria included studies on individuals aged ≥18, based on Rome III/IV criteria, using random or convenience sampling. Data on IBS prevalence, subtypes, and sampling methods were extracted, and statistical analysis was performed using Open MetaAnalyst and the review manager. The study reviewed 96 articles on IBS prevalence using Rome III and IV criteria across 52 countries, revealing a global prevalence of 14.1%. Prevalence varied by subtype: IBS-C (26.1%), IBS-D (26.5%), IBS-M (31.4%), and IBS-U (8.3%). IBS-D was more prevalent under Rome III (26.2%), while IBS-C was more common under Rome IV (34.2%). First-world countries like the UK, China, and Japan had the highest prevalence. Females [odds ratios (OR): 1.49], stress (OR: 2.47), anxiety (OR: 2.93), and depression (OR: 2.24) were significantly more prevalent in IBS patients, while no significant differences were found in smoking, alcohol use, or education levels. This meta-analysis reveals regional and subtype variations in IBS prevalence, with psychological factors significantly impacting its development. The influence of sampling techniques and Rome III/IV criteria on prevalence estimates highlights the need for a multidisciplinary treatment approach, with important implications for IBS management.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
Drossman, D. A. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.032 · Cited by 2,430
Sperber, A. D., Bangdiwala, S. I., Drossman, D. A., Ghoshal, U. C., Simren, M., Tack, J., Whitehead, W. E., Dumitrascu, D. L., Fang, X., Fukudo, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.04.014 · Cited by 2,263
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
Oka, P., Parr, H., Barberio, B., Black, C. J., Savarino, E. V., & Ford, A. C. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30217-x · Cited by 882
Functional gastrointestinal disorders: advances in understanding and management
Black, C. J., Drossman, D. A., Talley, N. J., Ruddy, J., & Ford, A. C. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32115-2 · Cited by 605
Meta‐analysis of prevalence: I 2 statistic and how to deal with heterogeneity
Migliavaca, C. B., Stein, C., Colpani, V., Barker, T. H., Ziegelmann, P. K., Munn, Z., Falavigna, M., & Prevalence Estimates Reviews—Systematic Review Methodology Group (PERSyst) (2022) · Research Synthesis Methods · doi:10.1002/jrsm.1547 · Cited by 577
Rome criteria and a diagnostic approach to irritable bowel syndrome
Lacy, B., & Patel, N. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6110099 · Cited by 575
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
Saha, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6759 · Cited by 500
Palsson, O. S., Whitehead, W., Törnblom, H., Sperber, A. D., & Simren, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.021 · Cited by 461
Barberio, B., Judge, C., Savarino, E. V., & Ford, A. C. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00111-4 · Cited by 422
Research works printed but not linked: 1
- Wang, 2012, A survey on relationship between onset of symptoms and food intake in patients with irritable bowel syndrome (in Chinese)., Chin J Gastroenterol, 17, 110
Cited by
Kovács, E., Szabo, K., Varvara, R.-A., Uifălean, A., Cozma, A., Vulturar, R., Sitar-Tăut, A., Gabbianelli, R., Myhrstad, M. C. W., Telle‐Hansen, V. H., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167753 · Cited by 29
Unraveling Chronic Pain: From Mechanisms and Risks to Diagnosis and Treatment
Dai, X., Wang, C., Jiang, P., & Mei, X. (2026) · MedComm · doi:10.1002/mco2.70685 · Cited by 17
Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies
Abalo, R., Gallego-Barceló, P., & Gabbia, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199345 · Cited by 5
“Various risk factors, such as mental stress, mainly in childhood, a previous transient infection or chronic low-grade inflammation of the GI tract, abnormal intestinal microbiota (dysbiosis), and dysfunction of colon motility have all been related to the development of IBS symptoms [35,36].”
Aggeletopoulou, I., Karaivazoglou, K., Kalafateli, M., & Triantos, C. K. (2025) · Nutrients · doi:10.3390/nu17223595 · Cited by 6
“Estimates based on stricter diagnostic criteria of Rome IV tend to fall between 3% and 5%, whereas broader, symptom-based studies report higher rates, typically between 10% and 15% [3–5].”
Kayali, S., Marabotto, E., Bodini, G., Marenco, S., Labanca, S., Pieri, G., Zentilin, P., Giannini, E. G., & Furnari, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238487 · Cited by 2
“In particular, our data are in line with the study by Huerta-Franco et al. and with the recent meta-analysis by Arif et al. who underlined the detrimental effect of occupational stress on chronic gastrointestinal diseases [19,21].”
Metadata
- Authors
- Arif, T. B., Ali, S. H., Bhojwani, K. D., Sadiq, M., Siddiqui, A. A., Ur-Rahman, A., Khan, M. Z., Hasan, F., & Shahzil, M.
- Affiliations
- George Washington University (US)
- Dow University of Health Sciences (PK)
- Cleveland Clinic Florida (US)
- Henry Ford Hospital (US)
- Cooper University Hospital (US)
- Pennsylvania State University (US)
- ORCID
- Venue
- European Journal of Gastroenterology & Hepatology
- Published
- 2025-04-30
- Volume
- 37
- Issue
- 12
- Pages
- 1314-1325
- ISSN
- 0954-691X (ISSN-L)
- 1473-5687
- OpenAlex
- W4410339547
- Semantic Scholar
- 25745313c079cbfce1ed2eccb480e5630ac7fd04
- Cited by
- 50
- References
- 155
- Citations by year
- 2026: 38 · 2025: 12
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- irritable bowel syndrome, global prevalence, Rome III criteria, Rome IV criteria, IBS subtypes, irritable bowel syndrome with constipation, diarrhea-predominant irritable bowel syndrome, IBS-M, risk factors, psychological factors, anxiety, depression, stress, sex differences, regional variation
- MeSH terms
- Female, Humans, Male, Risk Factors, Global Health, Prevalence, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: a meta-analysis. https://app.cochat.ai/papers/10.1097/meg.0000000000002994
- The paper
- Arif, T. B., Ali, S. H., Bhojwani, K. D., Sadiq, M., Siddiqui, A. A., Ur-Rahman, A., Khan, M. Z., Hasan, F., & Shahzil, M. (2025). Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: a meta-analysis. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000002994
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.